Life insurance with Crohn's disease depends on disease activity, treatment regimen, surgical history, and how long you have maintained remission. Crohn's is a chronic inflammatory bowel disease that ranges from mild intermittent symptoms to severe disease requiring multiple surgeries and biologic therapy. Carriers evaluate the full picture—not the diagnosis alone. The Crohn's & Colitis Foundation estimates roughly 780,000 Americans live with Crohn's disease; carriers have developed IBD underwriting guidelines that vary significantly between companies.
At Local Life Agents, we pre-screen inflammatory bowel disease files across 30+ A-rated carriers before formal application.
Key Takeaways
- Remission is the key word. Stable remission for two or more years with no recent flare opens Standard at multiple carriers.
- Biologics are common but rated. Humira, Remicade, Stelara, and other biologics signal moderate to severe IBD—usually Standard to Table 2, not decline.
- Surgery history matters. One bowel resection with stable follow-up is different from multiple surgeries with ongoing complications.
- Active flare means postpone. Applying during a flare with steroid dependence or hospitalization usually means postpone until remission is re-established.
- Ulcerative colitis follows similar rules. IBD underwriting treats Crohn's and UC with comparable guidelines at most carriers.
Compare Crohn's disease life insurance rates
Compare Crohn's disease rates at carriers whose IBD guidelines match your remission status and biologic therapy history.
What do underwriters look for with Crohn's disease?
IBD underwriting evaluates disease severity, treatment intensity, and stability over time.
- Disease activity — Active flare vs. remission; recent symptoms, weight loss, or anemia.
- Time in remission — How long since last flare; carriers typically want 12 to 24 months of stability.
- Medications — Mesalamine (mild) vs. immunomodulators (azathioprine, 6-MP) vs. biologics (TNF inhibitors) vs. chronic prednisone.
- Biologic therapy — Current biologic use indicates moderate to severe disease at most carriers but is insurable.
- Surgical history — Number of bowel resections, ostomy presence, and complications from surgery.
- Hospitalizations — IBD-related admissions within the past one to three years worsen offers.
- Nutritional status — Significant weight loss, malnutrition, or TPN dependence are serious flags.
- Colonoscopy surveillance — Regular screening with no dysplasia or cancer supports favorable ratings.
- Extra-intestinal manifestations — Arthritis, eye inflammation, or liver involvement (primary sclerosing cholangitis) compound risk.
Have your gastroenterology records ready: most recent colonoscopy, current medication list, and your GI's assessment of disease activity.
Application questions you'll see:
- When were you diagnosed with Crohn's disease?
- Is your disease currently active or in remission? When was your last flare?
- What medications do you take for Crohn's disease?
- Are you on biologic therapy (Humira, Remicade, Stelara, others)?
- Have you had bowel surgery? If so, how many resections and when?
- Have you been hospitalized for Crohn's disease? If so, when?
- Do you have an ostomy?
- When was your last colonoscopy, and were there any concerning findings?
How does Crohn's disease affect your life insurance rate class?
Mild Crohn's in long-term remission on mesalamine only with no surgeries and no recent flares often qualifies for Standard at carriers with favorable IBD guidelines.
Moderate Crohn's in remission on azathioprine or a biologic with one prior resection and stable follow-up typically lands Standard to Table 2.
Active Crohn's with recent flare, steroid dependence, weight loss, or hospitalization within the past year usually means postpone until remission is documented—then Table 2 to Table 4.
Multiple surgeries, short gut syndrome, chronic prednisone, or PSC (primary sclerosing cholangitis) usually means Table 4 or decline at standard carriers.
Ostomy presence is insurable at some carriers when the underlying disease is stable; others rate ostomies more conservatively.
Can you get standard rates with Crohn's disease?
Standard rates are realistic for mild to moderate Crohn's disease in documented remission. Mild Crohn's on mesalamine only with no surgeries and long-term remission often qualifies for Standard at carriers with favorable IBD guidelines. Moderate Crohn's on biologics with stable remission for twelve to twenty-four months typically lands Standard to Table 2. The key is timing—applying during a flare or immediately post-surgery usually means postpone, while applying with documented remission and stable treatment opens competitive offers. Understanding life insurance underwriting timelines across autoimmune conditions helps you know when to apply.
Which carriers handle Crohn's disease most competitively?
IBD guidelines vary. Principal and Lincoln have historically been among the more favorable for Crohn's in remission on biologics. Prudential and John Hancock often work for mild IBD on mesalamine. Severe cases with multiple surgeries may need impaired-risk pre-screening.
Do not apply during a flare. Wait until remission is documented with your gastroenterologist and at least 12 months of stability before applying.
Expert Tip: Time the application to remission
I had a client apply during a mild flare because he felt fine day to day. His CRP was elevated, he had started prednisone two months earlier, and the carrier postponed. We waited eight months, got a clean colonoscopy and normal inflammatory markers, and he was approved at Standard. Same person, different timing—that is how IBD underwriting works.
—Ryan Wood
Conclusion
Crohn's disease changes when and where you apply—not whether coverage is available for most remission-stable patients. Independent agents pre-screen IBD files across 30+ A-rated carriers because biologic tolerance and surgical history guidelines vary enough to mean Standard at one company and Table 4 at another. Applying during a flare or to the wrong carrier wastes MIB entries and months of waiting.
If your Crohn's is in remission with documented stability, competitive rates are realistic. If you are in active disease or recently post-surgery, we map when to reapply and pre-screen at favorable carriers when the time is right. Return to our life insurance hub for product guides and coverage types.
Life Insurance
See what you'd pay — run your numbers across 30+ A-rated carriers in about 2 minutes.
Run My Numbers